When was Hubei Guangji Pharmaceutical founded?

Hubei Guangji Pharmaceutical was founded in 1969 and raised its 1st funding round 42 years after it was founded.

Where is Hubei Guangji Pharmaceutical located?

Hubei Guangji Pharmaceutical is headquartered in Hubei, China.

How many employees does Hubei Guangji Pharmaceutical have?

As of May 31, 2026, the latest employee count at Hubei Guangji Pharmaceutical is 3.

Is Hubei Guangji Pharmaceutical a funded company?

Hubei Guangji Pharmaceutical is a funded company, having raised a total of $***** in its 1st and only funding round, a Post IPO round on Jul 22, 2011.

When was the latest funding round of Hubei Guangji Pharmaceutical?

Hubei Guangji Pharmaceutical's latest funding was a $***** Post IPO round on Jul 22, 2011, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In China, the Biopharma Outsourcing sector has seen $50.6M in funding in 2026 to date.

Where does Hubei Guangji Pharmaceutical rank among its competitors?

Hubei Guangji Pharmaceutical ranks 144th amongst 953 active competitors, of which 38 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Enaltec Labs, which secured $1.33M in Jan, 2022.

Who are the top competitors of Hubei Guangji Pharmaceutical?

Hubei Guangji Pharmaceutical's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem. Among them, Enaltec Labs secured the most recent funding round in January, 2022.

Hubei Guangji Pharmaceutical - 2026 Company Profile, Funding & Competitors

Hubei Guangji Pharmaceutical is a public company based in Hubei (China), founded in 1969. It operates as a State-owned pharma that produces APIs, human and animal nutritional products. Hubei Guangji Pharmaceutical has raised an undisclosed amount in funding. The company has 953 active competitors, including 38 funded and 136 that have exited. Its top competitors include companies like Laurus Labs, Symbiotec and NGL Fine Chem.

Company Details

Hubei Guangji Pharmaceuticals is a state-owned pharmaceutical enterprise that manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations primarily in China. The company offers APIs, human nutritional products, and animal nutritional products. Its products include beta-carotene, and riboflavin sodium phosphate and vitamin products. In the market for its two main products riboflavin, tinidazole, GJPC tops its national counterparts in terms of output, quality, economic benefits and market share. More than 60 percent of its main products are exported to over 30 countries and regions all over the world.

Website: guangjipharm.com
Email ID: *****@guangjipharm.china.com

Key Metrics

Founded Year

1969

Location

Hubei, China

Stage

Public

Latest Funding Round

Post IPO, Jul 22, 2011, $*****

Investors

Millennium Ark Capital

Ranked

144^th among 953 active competitors

Employee Count

3 as on May 31, 2026

Similar Companies

Laurus Labs & 1217 more

Exit Details

Public

View Hubei Guangji Pharmaceutical's full profile

Hubei Guangji Pharmaceutical has raised funding over 1 round. Its latest funding round was a Post IPO round on Jul 22, 2011 for $*****. 1 investor participated in its latest round. Hubei Guangji Pharmaceutical has 1 institutional investor.

Here is the list of recent funding rounds of Hubei Guangji Pharmaceutical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 22, 2011	1659728	Post IPO	4495761	9870292	8218286	7254850

Access funding benchmarks and valuations. Sign up today!

View details of Hubei Guangji Pharmaceutical's funding rounds and investors

Hubei Guangji Pharmaceutical's employee count trend

Hubei Guangji Pharmaceutical has 3 employees as of May 26. Here is Hubei Guangji Pharmaceutical's employee count trend over the years:

Employee count trend for Hubei Guangji Pharmaceutical

Uncover Hubei Guangji Pharmaceutical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Hubei Guangji Pharmaceutical include Laurus Labs, Symbiotec and NGL Fine Chem. Here is the list of Top 10 competitors of Hubei Guangji Pharmaceutical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Laurus Labs 2005, Hyderabad (India), Public	Pharmaceutical and biotechnology company	$230M	IKP Knowledge Park, Eight Roads Ventures & 3 others	70/100
2nd	Symbiotec 2002, Indore (India), Acquired	Manufacturer of non sterile steroid hormone based APIs and intermediates	$61.1M	Franklin Templeton Investments, Actis & 21 others	63/100
3rd	NGL Fine Chem 1981, Mumbai (India), Public	CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals	-	-	59/100
4th	Neuland 1984, Hyderabad (India), Public	Manufacturer of active pharmaceutical ingredients (APIs) and peptides	-	InvAscent, India Capital Growth & 1 others	58/100
5th	Embio 1986, Mumbai (India), Early Stage	Contract research and manufacturing company engaged in APIs and chiral intermediates	$292K	UTI, GURU NARAYAN FINCAP & 25 others	57/100
6th	Hikal 1988, Mumbai (India), Public	Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates	-	IFC	57/100
7th	IDT Australia Limited 1975, Boronia (Australia), Public	Providing cannabis product development and manufacturing services from API	$6M	CVC, I'Rom Group	54/100
8th	ST PHARM 2008, Siheung si (South Korea), Public	CDMO providing oligonucleotide, mRNA, and small molecule services	-	E&Investment, Shinhan Venture Investment & 1 others	53/100
9th	Enaltec Labs 2006, Mumbai (India), Acquired	Provider of complex small-volume technology-driven pharmaceutical products	$8.56M	InvAscent, Medtech Global & 7 others	52/100
10th	SeQuent 2002, Bengaluru (India), Acquired	APIs Manufacturer	-	Thecarlylegroup.fr, Nepean Capital & 2 others	50/100
144th	Hubei Guangji Pharmaceutical 1969, Hubei (China), Public	State-owned pharma that produces APIs, human and animal nutritional products	-	Millennium Ark Capital	35/100